Telmisartan prevents high-fat diet-induced hypertension and decreases perirenal fat in rats

Journal of Biomedical Research

Volumn 26, Issue 3, 2012, Pages 219-225

  Wang, Yaping ^a   Song, Yan ^a   Suo, Meng ^a   Jin, Xin ^a   Tian, Gang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Adiponectin; High fat diet; Hypertension; Perirenal fat; Telmisartan

Indexed keywords

ADIPONECTIN; INSULIN; MESSENGER RNA; TELMISARTAN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DYSLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; MALE; NONHUMAN; PERIRENAL FAT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 84862170951     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.26.20120013     Document Type: Article

References (35)

1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analy-sis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million partici-pants. Lancet 2011, 377:557-567.
2. Nichols M, de Silva-Sanigorski A, Cleary J, Goldfeld S, Colahan A, Swinburn B Decreasing trends in over-weight and obesity among an Australian population of preschool children. Int J Obes (Lond) 2011, 35:916-924.
3. Aneja A, El-Atat F, McFarlane SI, Sowers JR Hyper-tension and obesity. Recent Prog Horm Res 2004, 59:169-205.
4. Sironi AM, Pingitore A, Ghione S, De Marchi D, Scat-tini B, Positano V, et al. Early hypertension is associated with reduced regional cardiac function, insulin resist-ance, epicardial, and visceral fat. Hypertension 2008, 51:282-288.
5. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Mu-rabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardio-vascular disease burden: the Framingham Heart Study. Eur Heart J 2009, 30:850.
6. Saitoh S, Akasaka H, Mitsumata K, Chiba M, Furu-gen M, Furukawa T, et al. Incidence of hypertension in individuals with abdominal obesity in a rural Japanese population: the Tanno and Sobetsu study. Hypertens Res 2008, 31:1385-1390.
7. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melano-cortins. J Biol Chem 2010, 285:17271.
8. Dixon JB The effect of obesity on health outcomes. Mol Cell Endocrinol 2010, 316:104-108.
9. Wang Y, Beydoun MA, Liang L, Caballero B, Ku-manyika SK Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008, 16:2323-2330.
10. Makita S, Abiko A, Naganuma Y, Moriai Y, Nakamura M Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance. Metabolism 2008, 57:1473-1478.
11. Mori Y, Itoh Y, Tajima N Telmisartan improves lipid metabolism and adiponectin production but does not af-fect glycemic control in hypertensive patients with type 2 diabetes. Adv Ther 2007, 24:146-153.
12. Komiya N, Hirose H, Kawabe H, Itoh H, Saito I Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (HMW)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity. J Atheroscler Thromb 2009, 16:137.
13. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabe-tes 2008, 57:1269.
14. öhman MK, Shen Y, Obimba CI, Wright AP, Warnock M, Lawrence DA, et al. Visceral Adipose Tissue In-flammation Accelerates Atherosclerosis in Apolipopro-tein E-Deficient Mice. Circulation 2008, 117:798-805.
15. Dolinkova M, Dostalova I, Lacinova Z, Michalsky D, Haluzikova D, Mraz M, et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol 2008, 291:63-70.
16. Jensen MD Role of body fat distribution and the meta-bolic complications of obesity. J Clin Endocrinol Metab 2008, 93(S):57.
17. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of besity. Metabolism 2001, 50:425-435.
18. Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L, et al. Para-and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuri-caemia in type-2 diabetic patients. Nephrol Dial Trans-plant 2011, 26:892.
19. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, et al. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adi-posity and microvascular proliferation. Am J Physiol Renal Physiol 2011, 301:F1078-F1087.
20. Khanal RC, Rogers TJ, Wilkes SE, Howard LR, Prior RL Effects of dietary consumption of cranberry powder on metabolic parameters in growing rats fed high fruc-tose diets. Food Funct 2010, 1:116-123.
21. Su H, Zhang Z, Pan L, Guo Y, Liu Y, Zhang Q Meta-bolic characteristics of a fatty liver disease model in-duced by high-fat feeding in young rats]. Zhonghua gan zang bing za zhi 2010, 18:54.
22. Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H Telmisartan prevents obesity and in-creases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 2006, 48:51-57.
23. Moriuchi A, Yamasaki H, Shimamura M, Kita A, Ku-wahara H, Fujishima K, et al. Induction of human adi-ponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-[gamma] acti-vation. Biochem Biophys Res Commun 2007, 356:1024-1030.
24. Souza-Mello V, Gregorio B, Cardoso-de-Lemos F, de Carvalho L, Aguila M, Mandarim-de-Lacerda C Com-parative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond) 2010, 119:239-250.
25. Furuhashi M, Hotamisligil GS Fatty acid-binding pro-teins: role in metabolic diseases and potential as drug targets. Biochem Biophys Res Commun 2008, 7:489-503.
26. Tinahones F, Garrido-Sanchez L, Miranda M, García-Almeida J, Macias-Gonzalez M, Ceperuelo V, et al. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 2010, 20:1559-1567.
27. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsu-zawa Y, Makishima M, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655.
28. Wen JP, Liu C, Hu YT, Chen G, Lin L Globular adi-ponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK/ACC) pathway in the hypothalamus. Mol Cell Biochem 2010, 1-7.
29. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM Adi-ponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-κB pathway. J Immunol 2007, 179:5483.
30. Ajuwon KM, Spurlock ME Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. American Journal of Physiology-Regulatory, Am J Physiol Regul Integr Comp Physiol 2005, 288:R1220-R1225.
31. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Mau-rovich-Horvat P, Larson MG, et al. Visceral and sub-cutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. Circulation 2007, 116:1234-1241.
32. Karunakaran I, Mohan AR, Jayagaopi S, Viswanathan M Association of visceral and subcutaneous fat with glu-cose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011, 44:281-287.
33. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 2008, 16:522-530.
34. Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Del Giglio M, et al. Predictors of ectopic fat accu-mulation in liver and pancreas in obese men and women. Obesity 2011, 19:1747-1754.
35. Rea D, Heimbach J, Grande J, Textor S, Taler S, Pri-eto M, et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006, 70:1636-1641.